Literature DB >> 30169737

PDV: an integrative proteomics data viewer.

Kai Li1,2, Marc Vaudel3,4, Bing Zhang5,6, Yan Ren1,2, Bo Wen5,6.   

Abstract

SUMMARY: Data visualization plays critical roles in proteomics studies, ranging from quality control of MS/MS data to validation of peptide identification results. Herein, we present PDV, an integrative proteomics data viewer that can be used to visualize a wide range of proteomics data, including database search results, de novo sequencing results, proteogenomics files, MS/MS data in mzML/mzXML format and data from public proteomics repositories. PDV is a lightweight visualization tool that enables intuitive and fast exploration of diverse, large-scale proteomics datasets on standard desktop computers in both graphical user interface and command line modes.
AVAILABILITY AND IMPLEMENTATION: PDV software and the user manual are freely available at http://pdv.zhang-lab.org. The source code is available at https://github.com/wenbostar/PDV and is released under the GPL-3 license. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Mesh:

Substances:

Year:  2019        PMID: 30169737      PMCID: PMC6821182          DOI: 10.1093/bioinformatics/bty770

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  17 in total

1.  PepNovo: de novo peptide sequencing via probabilistic network modeling.

Authors:  Ari Frank; Pavel Pevzner
Journal:  Anal Chem       Date:  2005-02-15       Impact factor: 6.986

2.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

Review 3.  Viewing the proteome: how to visualize proteomics data?

Authors:  Eystein Oveland; Thilo Muth; Erdmann Rapp; Lennart Martens; Frode S Berven; Harald Barsnes
Journal:  Proteomics       Date:  2015-01-21       Impact factor: 3.984

4.  MS-viewer: a web-based spectral viewer for proteomics results.

Authors:  Peter R Baker; Robert J Chalkley
Journal:  Mol Cell Proteomics       Date:  2014-03-03       Impact factor: 5.911

5.  De novo peptide sequencing by deep learning.

Authors:  Ngoc Hieu Tran; Xianglilan Zhang; Lei Xin; Baozhen Shan; Ming Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

6.  BatMass: a Java Software Platform for LC-MS Data Visualization in Proteomics and Metabolomics.

Authors:  Dmitry M Avtonomov; Alexander Raskind; Alexey I Nesvizhskii
Journal:  J Proteome Res       Date:  2016-06-28       Impact factor: 4.466

7.  PRIDE Inspector: a tool to visualize and validate MS proteomics data.

Authors:  Rui Wang; Antonio Fabregat; Daniel Ríos; David Ovelleiro; Joseph M Foster; Richard G Côté; Johannes Griss; Attila Csordas; Yasset Perez-Riverol; Florian Reisinger; Henning Hermjakob; Lennart Martens; Juan Antonio Vizcaíno
Journal:  Nat Biotechnol       Date:  2012-02-08       Impact factor: 54.908

8.  Novor: real-time peptide de novo sequencing software.

Authors:  Bin Ma
Journal:  J Am Soc Mass Spectrom       Date:  2015-06-30       Impact factor: 3.109

9.  Detection of Proteome Diversity Resulted from Alternative Splicing is Limited by Trypsin Cleavage Specificity.

Authors:  Xiaojing Wang; Simona G Codreanu; Bo Wen; Kai Li; Matthew C Chambers; Daniel C Liebler; Bing Zhang
Journal:  Mol Cell Proteomics       Date:  2017-12-08       Impact factor: 5.911

10.  The proBAM and proBed standard formats: enabling a seamless integration of genomics and proteomics data.

Authors:  Gerben Menschaert; Xiaojing Wang; Andrew R Jones; Fawaz Ghali; David Fenyö; Volodimir Olexiouk; Bing Zhang; Eric W Deutsch; Tobias Ternent; Juan Antonio Vizcaíno
Journal:  Genome Biol       Date:  2018-01-31       Impact factor: 13.583

View more
  27 in total

1.  Uncovering Thousands of New Peptides with Sequence-Mask-Search Hybrid De Novo Peptide Sequencing Framework.

Authors:  Korrawe Karunratanakul; Hsin-Yao Tang; David W Speicher; Ekapol Chuangsuwanich; Sira Sriswasdi
Journal:  Mol Cell Proteomics       Date:  2019-10-07       Impact factor: 5.911

2.  Proteogenomic Characterization of Endometrial Carcinoma.

Authors:  Yongchao Dou; Emily A Kawaler; Daniel Cui Zhou; Marina A Gritsenko; Chen Huang; Lili Blumenberg; Alla Karpova; Vladislav A Petyuk; Sara R Savage; Shankha Satpathy; Wenke Liu; Yige Wu; Chia-Feng Tsai; Bo Wen; Zhi Li; Song Cao; Jamie Moon; Zhiao Shi; MacIntosh Cornwell; Matthew A Wyczalkowski; Rosalie K Chu; Suhas Vasaikar; Hua Zhou; Qingsong Gao; Ronald J Moore; Kai Li; Sunantha Sethuraman; Matthew E Monroe; Rui Zhao; David Heiman; Karsten Krug; Karl Clauser; Ramani Kothadia; Yosef Maruvka; Alexander R Pico; Amanda E Oliphant; Emily L Hoskins; Samuel L Pugh; Sean J I Beecroft; David W Adams; Jonathan C Jarman; Andy Kong; Hui-Yin Chang; Boris Reva; Yuxing Liao; Dmitry Rykunov; Antonio Colaprico; Xi Steven Chen; Andrzej Czekański; Marcin Jędryka; Rafał Matkowski; Maciej Wiznerowicz; Tara Hiltke; Emily Boja; Christopher R Kinsinger; Mehdi Mesri; Ana I Robles; Henry Rodriguez; David Mutch; Katherine Fuh; Matthew J Ellis; Deborah DeLair; Mathangi Thiagarajan; D R Mani; Gad Getz; Michael Noble; Alexey I Nesvizhskii; Pei Wang; Matthew L Anderson; Douglas A Levine; Richard D Smith; Samuel H Payne; Kelly V Ruggles; Karin D Rodland; Li Ding; Bing Zhang; Tao Liu; David Fenyö
Journal:  Cell       Date:  2020-02-13       Impact factor: 41.582

3.  Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors.

Authors:  Assaf Kacen; Aaron Javitt; Matthias P Kramer; David Morgenstern; Tomer Tsaban; Merav D Shmueli; Guo Ci Teo; Felipe da Veiga Leprevost; Eilon Barnea; Fengchao Yu; Arie Admon; Lea Eisenbach; Yardena Samuels; Ora Schueler-Furman; Yishai Levin; Alexey I Nesvizhskii; Yifat Merbl
Journal:  Nat Biotechnol       Date:  2022-10-06       Impact factor: 68.164

4.  Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance.

Authors:  Zhentao Yang; Yan Wang; Sixue Liu; Weixian Deng; Shirley H Lomeli; Gatien Moriceau; James Wohlschlegel; Marco Piva; Roger S Lo
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

5.  Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

Authors:  David J Clark; Saravana M Dhanasekaran; Francesca Petralia; Jianbo Pan; Xiaoyu Song; Yingwei Hu; Felipe da Veiga Leprevost; Boris Reva; Tung-Shing M Lih; Hui-Yin Chang; Weiping Ma; Chen Huang; Christopher J Ricketts; Lijun Chen; Azra Krek; Yize Li; Dmitry Rykunov; Qing Kay Li; Lin S Chen; Umut Ozbek; Suhas Vasaikar; Yige Wu; Seungyeul Yoo; Shrabanti Chowdhury; Matthew A Wyczalkowski; Jiayi Ji; Michael Schnaubelt; Andy Kong; Sunantha Sethuraman; Dmitry M Avtonomov; Minghui Ao; Antonio Colaprico; Song Cao; Kyung-Cho Cho; Selim Kalayci; Shiyong Ma; Wenke Liu; Kelly Ruggles; Anna Calinawan; Zeynep H Gümüş; Daniel Geiszler; Emily Kawaler; Guo Ci Teo; Bo Wen; Yuping Zhang; Sarah Keegan; Kai Li; Feng Chen; Nathan Edwards; Phillip M Pierorazio; Xi Steven Chen; Christian P Pavlovich; A Ari Hakimi; Gabriel Brominski; James J Hsieh; Andrzej Antczak; Tatiana Omelchenko; Jan Lubinski; Maciej Wiznerowicz; W Marston Linehan; Christopher R Kinsinger; Mathangi Thiagarajan; Emily S Boja; Mehdi Mesri; Tara Hiltke; Ana I Robles; Henry Rodriguez; Jiang Qian; David Fenyö; Bing Zhang; Li Ding; Eric Schadt; Arul M Chinnaiyan; Zhen Zhang; Gilbert S Omenn; Marcin Cieslik; Daniel W Chan; Alexey I Nesvizhskii; Pei Wang; Hui Zhang
Journal:  Cell       Date:  2019-10-31       Impact factor: 41.582

6.  Parthenolide Destabilizes Microtubules by Covalently Modifying Tubulin.

Authors:  Takashi Hotta; Sarah E Haynes; Teresa L Blasius; Margo Gebbie; Emily L Eberhardt; David Sept; Michael Cianfrocco; Kristen J Verhey; Alexey I Nesvizhskii; Ryoma Ohi
Journal:  Curr Biol       Date:  2021-01-21       Impact factor: 10.834

7.  Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.

Authors:  Chen Huang; Lijun Chen; Sara R Savage; Rodrigo Vargas Eguez; Yongchao Dou; Yize Li; Felipe da Veiga Leprevost; Eric J Jaehnig; Jonathan T Lei; Bo Wen; Michael Schnaubelt; Karsten Krug; Xiaoyu Song; Marcin Cieślik; Hui-Yin Chang; Matthew A Wyczalkowski; Kai Li; Antonio Colaprico; Qing Kay Li; David J Clark; Yingwei Hu; Liwei Cao; Jianbo Pan; Yuefan Wang; Kyung-Cho Cho; Zhiao Shi; Yuxing Liao; Wen Jiang; Meenakshi Anurag; Jiayi Ji; Seungyeul Yoo; Daniel Cui Zhou; Wen-Wei Liang; Michael Wendl; Pankaj Vats; Steven A Carr; D R Mani; Zhen Zhang; Jiang Qian; Xi S Chen; Alexander R Pico; Pei Wang; Arul M Chinnaiyan; Karen A Ketchum; Christopher R Kinsinger; Ana I Robles; Eunkyung An; Tara Hiltke; Mehdi Mesri; Mathangi Thiagarajan; Alissa M Weaver; Andrew G Sikora; Jan Lubiński; Małgorzata Wierzbicka; Maciej Wiznerowicz; Shankha Satpathy; Michael A Gillette; George Miles; Matthew J Ellis; Gilbert S Omenn; Henry Rodriguez; Emily S Boja; Saravana M Dhanasekaran; Li Ding; Alexey I Nesvizhskii; Adel K El-Naggar; Daniel W Chan; Hui Zhang; Bing Zhang
Journal:  Cancer Cell       Date:  2021-01-07       Impact factor: 31.743

8.  A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).

Authors:  Andrew T Rajczewski; Subina Mehta; Dinh Duy An Nguyen; Björn Grüning; James E Johnson; Thomas McGowan; Timothy J Griffin; Pratik D Jagtap
Journal:  Clin Proteomics       Date:  2021-05-10       Impact factor: 5.000

9.  TopMSV: A Web-Based Tool for Top-Down Mass Spectrometry Data Visualization.

Authors:  In Kwon Choi; Tianze Jiang; Sreekanth Reddy Kankara; Si Wu; Xiaowen Liu
Journal:  J Am Soc Mass Spectrom       Date:  2021-03-29       Impact factor: 3.262

10.  A proteogenomic portrait of lung squamous cell carcinoma.

Authors:  Shankha Satpathy; Karsten Krug; Pierre M Jean Beltran; Sara R Savage; Francesca Petralia; Chandan Kumar-Sinha; Yongchao Dou; Boris Reva; M Harry Kane; Shayan C Avanessian; Suhas V Vasaikar; Azra Krek; Jonathan T Lei; Eric J Jaehnig; Tatiana Omelchenko; Yifat Geffen; Erik J Bergstrom; Vasileios Stathias; Karen E Christianson; David I Heiman; Marcin P Cieslik; Song Cao; Xiaoyu Song; Jiayi Ji; Wenke Liu; Kai Li; Bo Wen; Yize Li; Zeynep H Gümüş; Myvizhi Esai Selvan; Rama Soundararajan; Tanvi H Visal; Maria G Raso; Edwin Roger Parra; Özgün Babur; Pankaj Vats; Shankara Anand; Tobias Schraink; MacIntosh Cornwell; Fernanda Martins Rodrigues; Houxiang Zhu; Chia-Kuei Mo; Yuping Zhang; Felipe da Veiga Leprevost; Chen Huang; Arul M Chinnaiyan; Matthew A Wyczalkowski; Gilbert S Omenn; Chelsea J Newton; Stephan Schurer; Kelly V Ruggles; David Fenyö; Scott D Jewell; Mathangi Thiagarajan; Mehdi Mesri; Henry Rodriguez; Sendurai A Mani; Namrata D Udeshi; Gad Getz; James Suh; Qing Kay Li; Galen Hostetter; Paul K Paik; Saravana M Dhanasekaran; Ramaswamy Govindan; Li Ding; Ana I Robles; Karl R Clauser; Alexey I Nesvizhskii; Pei Wang; Steven A Carr; Bing Zhang; D R Mani; Michael A Gillette
Journal:  Cell       Date:  2021-08-05       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.